


Changing Preventative Care in the Middle East
Preventative Care in the Middle East: A New Era Begins Preventative healthcare in the Middle East is undergoing a significant transformation. With chronic diseases on the rise and late-stage diagnoses still far too common, the introduction of innovative diagnostics,...
PanTum Detect® Now Available at the Doctors Centre Polyclinic in Dubai
Transforming the way we approach cancer detection in the UAE We’re excited to announce that RMDM Group’s PanTum Detect® blood test is officially live at the Doctors Centre Polyclinic in Dubai. RMDM, a partner in Doctors Centre Polyclinic, introduces an early detection...
Reducing Late-Stage Diagnoses: How PanTum Detect Fits into Emerging MCED Strategies
Dr Letizia Gulino, Head of Science & Technology, RMDM Group In recent decades, medical science has made tremendous progress in the early detection of certain cancers. However, the current approach remains fragmented and selective: while screening programs exist...
Harnessing Sugar’s Dual Role in Cancer: From Fuel to Therapeutic Target
Sugar as Cellular Fuel and Cancer Detection Tool Sugar, particularly glucose, is essential for cellular energy—but in cancer, it plays a more complex role. Cancer cells are notorious for consuming glucose at unusually high rates to support rapid growth. This...
New Research Links Sugar-Sweetened Beverages to Oral Cavity Cancer Risk in Women
A recent study published in JAMA Otolaryngology has uncovered a concerning link between the consumption of sugar-sweetened beverages (SSBs) and an increased risk of oral cavity cancer in women, including both smokers and non-smokers. The findings show that women who...
Advancing Prostate Cancer Detection: The Role of AI and Blood-Based Screening
The recent breakthrough in prostate cancer screening with the AI-powered test developed by EDX Medical Group represents a significant advancement in early cancer detection. By analysing more than 100 biological markers through blood and urine samples, this test could...
NHS Backlogs, Less Rhetoric and More Solutions by Dr. Letizia Gulino, Head of Science and Technology RMDM
We are witnessing a crucial moment for the NHS as it promises to reduce waiting lists and deliver timely care. This commitment resonates with patients and healthcare professionals. However, while the intentions behind these proposals are laudable, critical questions...
Reforming Prostate Cancer Testing: Chris Hoy’s Urgent Appeal for Change
Cancer is a major global health concern, but it’s typically associated with older age. However, in recent years, there has been a clear rise in younger individuals who have early-onset cancer. In this article, we will break down the findings of a study conducted in...
Government and Tech Innovators Unite to Advance Cancer Detection: The Potential of Pantum Detect
In a recent press release, the UK government outlined an initiative to boost tech deals aimed at further innovating cancer diagnosis in the country. This plan follows the Darzi review, which highlighted the critical state of the NHS, particularly the urgent need to...
Darzi Report Findings: The Urgent Need for Innovative Technology in NHS Cancer Care
In the House of Commons, Health Secretary Wes Streeting introduced a “national mission” to tackle key health challenges. Presenting the Darzi report, commissioned by the Labour government, he outlined the NHS’s ongoing struggles in the post-pandemic...
The UK’s Approach to Multi-Cancer Detection Tests
Last month, the UK National Screening Committee (UK NSC) shared their updated view on Multi-Cancer Detection (MCD) tests. They highlighted the potential and the immediate need for a multi-cancer detection solution in the UK. They are working to outline a roadmap for...
Why Multi-Cancer Early Detection Tests are the Future
Historically, early detection has focused on routine screenings for only a handful of cancers, such as breast, colorectal, cervical, lung, and prostate cancers. However, these screenings are not always effective. Many cancers are still detected at later stages when...
The Problem with the Cancer Waiting Time Crisis
Last month the BBC revealed that “cancer waiting times for 2023 in England were the worst on record”. Only 64.1% of patients started treatment within 62 days of a cancer suspicion, meaning nearly 100,000 waited longer than they should for life-saving care. These...
The Effect of TKTL1 in Breast Cancer: A Biomarker for Early Detection
Breast cancer is the second leading cause of cancer-related deaths in women. Thanks to pioneering research and diagnostic tests, we are discovering solutions to detect breast cancer early on. The TKTL1 gene, in particular, represents an incredible leap in our...
Scientists transform breast cancer cells from treatment-resistant into treatment-sensitive
Scientists may have found a solution to treat an aggressive, treatment-resistant type of breast cancer. A new study suggests it is possible to change an aggressive type of breast cancer into a non-aggressive type that responds well to common treatments. Scientists...
Scotland’s £10 Million Investment to Improve Cancer Care
This week we are excited to share the news of an incredible commitment to early cancer detection by the Scottish Government. A £10 million fund has been granted to improve cancer waiting times. The fund will enable the NHS in Scotland to invest in staff skills, new...
COVID-19 Hits Breast Cancer Screenings
Breast cancer is the most common cancer in the UK, with around 12,000 women diagnosed with the condition every year. Unfortunately, this week an analysis of NHS England figures by Cancer Research UK has found that around 10,600 fewer women started treatment for breast...
Cervical Cancer and the Need For Less Invasive Screening
Did you know 14th – 20th June 2021 is cervical screening awareness week? Cervical screening, also known as a smear test, is used to check the health of the cervix. It’s also the primary method used of detecting abnormal cells early, before they develop into cancer....
Focus on Cancer Research: For Diagnosis and Treatment
In some parts of the world, May is National Cancer Research Month – a month dedicated to highlighting the importance of lifesaving research into the devastating group of diseases collectively called cancer. Cancer affects millions of people across the...